P243
THRIVE-2 Phase 3 Trial of Veligrotug in Chronic Thyroid Eye Disease (TED): Efficacy, Safety, and Quality of Life at 15 Weeks
Jimmy Uddin, Antonio Manuel Garrido-Hermosilla, Michael Schittkowski, Onur Konuk, Anja Eckstein, Adrienne Csutak
Poster Presenter: Jimmy Uddin
